# OnCo record qurient (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/qurient/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "qurient" ;
  schema:name "Qurient"@en ;
  schema:alternateName "Qurient Co., Ltd."@en, "Qurient Co Ltd"@en ;
  schema:description "Qurient is a South Korean biotechnology company in Seongnam that leads two cancer trials in OnCo, testing the selective CDK7 inhibitor Q901 and the Axl/Mer/CSF1R inhibitor Q702, each with pembrolizumab, in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/qurient/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.wikidata.org/wiki/Q30253835>, <https://clinicaltrials.gov/search?lead=Qurient%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor", "wave5-sponsor" ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/axl/>, <https://onco.cc/targets/csf1r/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:trials <https://onco.cc/trials/nct05394103/>, <https://onco.cc/trials/nct05438420/> .